Los Angeles Capital Management’s Apyx Medical APYX Stock Holding History

Los Angeles Capital Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,965	Closed	-$268K	–	1320
2022 Q1	$268K	Buy	40,965 +13,260	+48%	+$131K	﹤0.01%	1282
2021 Q4	$355K	Hold	27,705	–	–	﹤0.01%	1171
2021 Q3	$384K	Sell	27,705 -8,113	-23%	-$85.3K	﹤0.01%	1178
2021 Q2	$369K	Sell	35,818 -22,679	-39%	-$225K	﹤0.01%	1304
2021 Q1	$565K	Buy	58,497 +870	+2%	+$8.7K	﹤0.01%	1168
2020 Q4	$415K	Sell	57,627 -1,830	-3%	-$12.1K	﹤0.01%	1273
2020 Q3	$280K	Buy	59,457 +19,402	+48%	+$96.1K	﹤0.01%	1293
2020 Q2	$222K	Buy	+40,055	New	+$166K	﹤0.01%	1370

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Los Angeles Capital Management's APYX Position: Q2 2022 in Review

Los Angeles Capital Management sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 40,965 shares — an estimated $268K sold.

Los Angeles Capital Management first reported a position in APYX in Q2 2020 and held it in 8 quarters. The position peaked at $565K in Q1 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Los Angeles Capital Management reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Los Angeles Capital Management sold 40,965 Apyx Medical shares in Q2 2022, an estimated $268K.
Los Angeles Capital Management first reported a position in Apyx Medical in Q2 2020 and held it in 8 quarters.
Los Angeles Capital Management's Apyx Medical position peaked at $565K in Q1 2021.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Los Angeles Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.